Hi EB,
I suspect one of the reasons for the tightening up of project finance is the rise of interest rates world wide. If this were to continue, they would need to do another cash raise again. Hence, the remark to embark on finalised plans to dual list in the US in 2019. A lot hinges on the growth of Aspiral and SUBRE and the decentralisation theme. If they are really the disrupter, the US will have no qualms of financing a CR. If it's just BOT and BOOT, then it may not get the attention because FLC is one of quite a few BOT operators, although I don't mean to diminish FLC's ability in this segment of biz.
2019 is really the proving to be crucial year for Aspiral. The SOE's in the likes of iTest need to harness the current monetary conditions while the state is still prepared to spend of infrastructure. I hope that is the case for the rest of 22 partners.
The US placees who took the placement probably see the same opportunities as we do. Hence the condition to come in at 37cts. Their timing was impeccable. Astute planning by whoever is working on FLC's capital structure (Paul Donnelly?). Whoever is planning this is an old hand in the game, a strategist, a pro.
Regards, YW.
Media Update, page-14
Add FLC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.005(2.94%) |
Mkt cap ! $188.3M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.5¢ | 16.5¢ | $26.79K | 157.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3373 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 142399 | 5 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
17.5¢ |
Change
0.005 ( 5.93 %) |
||||
| Open | High | Low | Volume | ||
| 16.5¢ | 17.5¢ | 16.5¢ | 39332 | ||
| Last updated 15.59pm 26/04/2024 ? | |||||
| FLC (ASX) Chart |